Sp1294
BOWEL URGENCY IN ULCERATIVE COLITIS
Date
May 7, 2023
Society: DDW
Sponsored by Lilly USA
Sponsored by Lilly USA
Presenter
Speakers
Northwestern Feinberg School of Medicine
Tracks
Related Products
SURVODUTIDE REDUCES LIVER FAT CONTENT, TRANSAMINASES, AND FIBROSIS MARKERS WITH GOOD SAFETY PROFILE IN PEOPLE WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): AN INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL
BACKGROUND: Survodutide is a novel glucagon receptor/glucagon-like peptide-1 receptor dual agonist under investigation for treatment in advanced liver disease associated with metabolic dysfunction-associated steatohepatitis (MASH), the most severe form of metabolic dysfunction-associated steatotic…
PERSISTENCE OF SPLANCHNIC GENE SIGNATURE DEFINES A TUMOR-RESTRAINING FIBROBLAST SUBTYPE IN PANCREATIC CANCER
The pancreas is composed of the epithelial and mesenchymal cells. Interaction between the two lineages guides proper formation of the pancreas and modulates progression of pancreatic diseases such as cancer…
CASE BY CASE: EXPLORING A PATIENT CASE IN THE TREATMENT OF MODERATE TO SEVERE CD
1) Examine clinical and objective treatment goals 2) Follow the journeys of patients with moderate to severe CD 3) Review the safety and efficacy for patients with moderate to severe CD Sponsored by AbbVie
Farron and Martin Brotman, MD, Lecture — IBD in 2025: Reviewing a Quarter Century of Progress
The landscape of treatment for IBD has evolved significantly over the past two decades. This session will examine advances in our understanding of disease pathogenesis and review treatment paradigm changes…
